Exclusive: Drug dealers to raise prices for 2021 as pandemic, political jeopardize revenue
By Michael Erman, Carl O’DonnellNEW YORK (Reuters) – Drug dealers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United…
